Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

The U.S. has been adept at inventing The Next Big Thing but sometimes stumbles when it comes to exploiting it. From cars to ...

The China fight is on. Last week, the House of Representatives stepped up to the Herculean task of passing 25 bills targeting ...

A rare-disease federal incentive program critical to biotech R&D is in jeopardy, writes Leslie Williams, president and CEO of ...

A machine operated by a Chinese military-linked biotech company is in use at one of the United States' most classified ...

From science fiction to reality GCTx is based around TFome, a cellular programming platform built to “plug and play”—that is, to deliver off-the-shelf induced pluripotent stem cell (iPSC ...

The global biotech giant is making a big bet on the South Philly campus, and says it’ll be hiring locally to fill the jobs.

The House Oversight Committee is aware of a machine operated by a Chinese military company that is in use at the nation’s ...

Charles River Laboratories International is cutting over ... Charles River, which provides contract research services to biotech and pharmaceutical companies, first announced the “restructuring ...

The interest rate cut expected this week has a potential double impact of opening financial options to emerging growth ...

Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, and Charles River Laboratories (Charles River), a global industry-leading drug discovery, preclinical ...